These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30219920)

  • 1. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
    Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study.
    Quigley CA; Child CJ; Zimmermann AG; Rosenfeld RG; Robison LL; Blum WF
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3195-3205. PubMed ID: 28575299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
    Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
    J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of recombinant human growth hormone in children.
    Bell J; Parker KL; Swinford RD; Hoffman AR; Maneatis T; Lippe B
    J Clin Endocrinol Metab; 2010 Jan; 95(1):167-77. PubMed ID: 19906787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Primary Cancer Incidence in Growth Hormone-Treated Children: Comparison of a Multinational Prospective Observational Study with Population Databases.
    Child CJ; Zimmermann AG; Jia N; Robison LL; Brämswig JH; Blum WF
    Horm Res Paediatr; 2016; 85(3):198-206. PubMed ID: 26913923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
    Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
    Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
    Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
    Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
    J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.
    Hartman ML; Xu R; Crowe BJ; Robison LL; Erfurth EM; Kleinberg DL; Zimmermann AG; Woodmansee WW; Cutler GB; Chipman JJ; Melmed S;
    J Clin Endocrinol Metab; 2013 Mar; 98(3):980-8. PubMed ID: 23345098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
    Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
    J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program.
    Child CJ; Zimmermann AG; Scott RS; Cutler GB; Battelino T; Blum WF;
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E1025-34. PubMed ID: 21490076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of growth hormone treatment in pediatric patients with idiopathic short stature.
    Quigley CA; Gill AM; Crowe BJ; Robling K; Chipman JJ; Rose SR; Ross JL; Cassorla FG; Wolka AM; Wit JM; Rekers-Mombarg LT; Cutler GB
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics.
    Albertsson-Wikland K; Mårtensson A; Sävendahl L; Niklasson A; Bang P; Dahlgren J; Gustafsson J; Kriström B; Norgren S; Pehrsson NG; Odén A
    J Clin Endocrinol Metab; 2016 May; 101(5):2149-59. PubMed ID: 26918292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Diabetes Treated in Early Adulthood After Growth Hormone Treatment of Short Stature in Childhood.
    Poidvin A; Weill A; Ecosse E; Coste J; Carel JC
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1291-1298. PubMed ID: 28324032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database).
    Wilton P; Mattsson AF; Darendeliler F
    J Pediatr; 2010 Aug; 157(2):265-70. PubMed ID: 20400105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program.
    Sävendahl L; Polak M; Backeljauw P; Blair J; Miller BS; Rohrer TR; Pietropoli A; Ostrow V; Ross J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4730-4742. PubMed ID: 31305924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.
    Cutfield WS; Wilton P; Bennmarker H; Albertsson-Wikland K; Chatelain P; Ranke MB; Price DA
    Lancet; 2000 Feb; 355(9204):610-3. PubMed ID: 10696981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.